{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:24:29Z","timestamp":1775132669859,"version":"3.50.1"},"reference-count":76,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxics"],"abstract":"<jats:p>PFAS are a group of synthetic chemicals that have been reported to be associated with adverse health outcomes. However, the relationship of PFAS exposure with psoriasis risk has not been reported. Utilizing data from the 2003\u20132018 NHANES, we explored the relationship of PFAS exposure with psoriasis risk. Our study included 5370 participants and examined serum levels of five PFAS compounds: PFOA, PFOS, PFHxS, PFNA, and PFDA, along with self-reported psoriasis status. Generalized linear regression, quantile g-computation, repeated hold out WQS regression, and BKMR models were employed to assess individual and combined effects of PFAS on psoriasis risk. We found each doubling the PFOS concentration was associated with a 19% increased risk of psoriasis (OR: 1.19; 95% CI: 1.01, 1.41) in the overall population. Sex-stratified analyses indicated significant associations between PFOA and PFNA exposure and psoriasis risk in females. Mixture analyses using WQS regression indicated that PFAS mixtures were associated with an 11% increased risk of psoriasis (OR: 1.11, 95% CI: 1.01, 1.22) in females in both the negative and positive direction. BKMR analyses also indicated a positive trend of PFAS mixtures with psoriasis risk in females. Our findings indicate a possible association between PFAS exposure and psoriasis risk, particularly in females.<\/jats:p>","DOI":"10.3390\/toxics12110828","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T11:58:07Z","timestamp":1732017487000},"page":"828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exposure to Per- and Polyfluoroalkyl Substances and Risk of Psoriasis: A Population-Based Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Public Health, Anhui Medical University, Hefei 230032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, The Second School of Clinical Medicine, Anhui Medical University, 81 Meishan Road, Hefei 230032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunxi","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Public Health, Anhui Medical University, Hefei 230032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.chemosphere.2012.03.035","article-title":"Perfluoroalkyl and polyfluoroalkyl substances (PFASs) in consumer products in Norway\u2013A pilot study","volume":"88","author":"Herzke","year":"2012","journal-title":"Chemosphere"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djp041","article-title":"Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population","volume":"101","author":"Eriksen","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ajim.23362","article-title":"Historical and current usage of per-and polyfluoroalkyl substances (PFAS): A literature review","volume":"66","author":"Gaines","year":"2023","journal-title":"Am. J. Ind. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.envres.2017.05.013","article-title":"Per-and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000\u20132015","volume":"157","author":"Olsen","year":"2017","journal-title":"Environ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"077005","DOI":"10.1289\/EHP6837","article-title":"Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington, North Carolina","volume":"128","author":"Kotlarz","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106123","DOI":"10.1016\/j.envint.2020.106123","article-title":"Human biomonitoring of per-and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019","volume":"145","author":"Weber","year":"2020","journal-title":"Environ. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.1021\/acs.est.7b03299","article-title":"Distribution of novel and well-known poly-and perfluoroalkyl substances (PFASs) in human serum, plasma, and whole blood","volume":"51","author":"Poothong","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108648","DOI":"10.1016\/j.envres.2019.108648","article-title":"Human exposure to per-and polyfluoroalkyl substances (PFAS) through drinking water: A review of the recent scientific literature","volume":"177","author":"Domingo","year":"2019","journal-title":"Environ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"Jama"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115357","DOI":"10.1016\/j.envres.2023.115357","article-title":"Systematic review and meta-analysis of birth weight and PFNA exposures","volume":"222","author":"Wright","year":"2023","journal-title":"Environ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"111632","DOI":"10.1016\/j.envres.2021.111632","article-title":"Per-and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: A systematic review and meta-analysis","volume":"201","author":"Gao","year":"2021","journal-title":"Environ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gui, S.-Y., Chen, Y.-N., Wu, K.-J., and Hu, C.-Y. (2022). Association between exposure to per-and polyfluoroalkyl substances and birth outcomes: A systematic review and meta-analysis. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.855348"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"110690","DOI":"10.1016\/j.envres.2020.110690","article-title":"PFAS and cancer, a scoping review of the epidemiologic evidence","volume":"194","author":"Steenland","year":"2021","journal-title":"Environ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly-and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0192623311428473","article-title":"Immunotoxicity of perfluorinated compounds: Recent developments","volume":"40","author":"DeWitt","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.taap.2014.06.020","article-title":"Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor \u03b3","volume":"279","author":"Zhang","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxsci\/kfl014","article-title":"Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat peroxisome proliferator-activated receptor-\u03b1, -\u03b2, and -\u03b3, liver X receptor-\u03b2, and retinoid X receptor-\u03b1","volume":"92","author":"Thompson","year":"2006","journal-title":"Toxicol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1021\/acs.est.9b00715","article-title":"Prenatal exposure to per-and polyfluoroalkyl substances (PFASs) and association between the placental transfer efficiencies and dissociation constant of serum proteins\u2013PFAS complexes","volume":"53","author":"Gao","year":"2019","journal-title":"Environ. Sci. Technol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yhbeh.2017.11.007","article-title":"Exposure to perfluoroalkyl substances during pregnancy and child behaviour at 5 to 9 years of age","volume":"101","author":"Bonde","year":"2018","journal-title":"Horm. Behav."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.rdc.2015.07.013","article-title":"Etiology and pathogenesis of psoriasis","volume":"41","author":"Boehncke","year":"2015","journal-title":"Rheum. Dis. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2022.11124","article-title":"Update on the etiopathogenesis of psoriasis","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Georgescu, S.-R., Tampa, M., Caruntu, C., Sarbu, M.-I., Mitran, C.-I., Mitran, M.-I., Matei, C., Constantin, C., and Neagu, M. (2019). Advances in understanding the immunological pathways in psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030739"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gaillard, L., Barouki, R., Blanc, E., Coumoul, X., and Andr\u00e9au, K. (2024). Per-and polyfluoroalkyl substances as persistent pollutants with metabolic and endocrine-disrupting impacts. Trends Endocrinol. Metab., S1043-2760(24)00202-9.","DOI":"10.1016\/j.tem.2024.07.021"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00204-022-03303-4","article-title":"Immunomodulation and exposure to per-and polyfluoroalkyl substances: An overview of the current evidence from animal and human studies","volume":"96","author":"Antoniou","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Woodlief, T., Vance, S., Hu, Q., and DeWitt, J. (2021). Immunotoxicity of per-and polyfluoroalkyl substances: Insights into short-chain PFAS exposure. Toxics, 9.","DOI":"10.3390\/toxics9050100"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/CIRCULATIONAHA.122.060911","article-title":"Status of cardiovascular health in US adults and children using the American Heart Association\u2019s new \u201cLife\u2019s Essential 8\u201d metrics: Prevalence estimates from the National Health and Nutrition Examination Survey (NHANES), 2013 through 2018","volume":"146","author":"Ning","year":"2022","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999\u2212 2008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetectable values","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","article-title":"Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults","volume":"158","author":"Ruan","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"164133","DOI":"10.1016\/j.scitotenv.2023.164133","article-title":"Associations of exposure to blood and urinary heavy metal mixtures with psoriasis risk among US adults: A cross-sectional study","volume":"887","author":"Chen","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"140683","DOI":"10.1016\/j.chemosphere.2023.140683","article-title":"Associations of individual and mixture exposure to volatile organic compounds with metabolic syndrome and its components among US adults","volume":"347","author":"Tan","year":"2024","journal-title":"Chemosphere"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"047004","DOI":"10.1289\/EHP5838","article-title":"A quantile-based g-computation approach to addressing the effects of exposure mixtures","volume":"128","author":"Keil","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13253-014-0180-3","article-title":"Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting","volume":"20","author":"Carrico","year":"2015","journal-title":"J. Agric. Biol. Environ. Stat."},{"key":"ref_36","unstructured":"Renzetti, S. (2021). The Weighted Quantile Sum Regression: Extensions and Applications. [Doctoral Thesis, Universit\u00e0 degli Studi di Milano]. Available online: https:\/\/air.unimi.it\/bitstream\/2434\/818694\/2\/phd_unimi_R11883.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"110341","DOI":"10.1016\/j.envres.2020.110341","article-title":"Prenatal maternal phthalate exposures and child lipid and adipokine levels at age six: A study from the PROGRESS cohort of Mexico City","volume":"192","author":"Kupsco","year":"2021","journal-title":"Environ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.mex.2019.11.008","article-title":"Repeated holdout validation for weighted quantile sum regression","volume":"6","author":"Tanner","year":"2019","journal-title":"MethodsX"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/biostatistics\/kxu058","article-title":"Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures","volume":"16","author":"Bobb","year":"2015","journal-title":"Biostatistics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106565","DOI":"10.1016\/j.envint.2021.106565","article-title":"Individual and joint effects of phthalate metabolites on biomarkers of oxidative stress among pregnant women in Puerto Rico","volume":"154","author":"Cathey","year":"2021","journal-title":"Environ. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12940-018-0413-y","article-title":"Statistical software for analyzing the health effects of multiple concurrent exposures via Bayesian kernel machine regression","volume":"17","author":"Bobb","year":"2018","journal-title":"Environ. Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J. Stat. Softw."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rappazzo, K.M., Coffman, E., and Hines, E.P. (2017). Exposure to perfluorinated alkyl substances and health outcomes in children: A systematic review of the epidemiologic literature. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14070691"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119505","DOI":"10.1016\/j.envpol.2022.119505","article-title":"Evaluated serum perfluoroalkyl acids and their relationships with the incidence of rheumatoid arthritis in the general population in Hangzhou, China","volume":"307","author":"Qu","year":"2022","journal-title":"Environ. Pollut."},{"key":"ref_45","first-page":"593","article-title":"Incidence of psoriasis and association with comorbidities in Italy: A 5-year observational study from a national primary care database","volume":"20","author":"Vena","year":"2010","journal-title":"Eur. J. Dermatol."},{"key":"ref_46","first-page":"18","article-title":"Psoriasis risk factors and triggers","volume":"102","author":"Lee","year":"2018","journal-title":"Cutis"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., and Ohtsuki, M. (2019). Risk factors for the development of psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184347"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.est.2c09315","article-title":"Verification of in vivo estrogenic activity for four per-and polyfluoroalkyl substances (PFAS) identified as estrogen receptor agonists via new approach methodologies","volume":"57","author":"Villeneuve","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"153031","DOI":"10.1016\/j.tox.2021.153031","article-title":"Per-and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease","volume":"465","author":"Rickard","year":"2022","journal-title":"Toxicology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1021\/acs.est.0c03468","article-title":"Evaluation of the estrogenic\/antiestrogenic activities of perfluoroalkyl substances and their interactions with the human estrogen receptor by combining in vitro assays and in silico modeling","volume":"54","author":"Li","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106408","DOI":"10.1016\/j.envint.2021.106408","article-title":"Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013\u20132016","volume":"149","author":"Wang","year":"2021","journal-title":"Environ. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.aller.2019.03.001","article-title":"Estrogen and estrogen receptor signaling promotes allergic immune responses: Effects on immune cells, cytokines, and inflammatory factors involved in allergy","volume":"47","author":"Fan","year":"2019","journal-title":"Allergol. Et Immunopathol."},{"key":"ref_54","first-page":"217","article-title":"Estrogens, the immune response and autoimmunity","volume":"13","author":"Cutolo","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chemosphere.2014.10.014","article-title":"Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro","volume":"129","author":"Long","year":"2015","journal-title":"Chemosphere"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"110361","DOI":"10.1016\/j.envres.2020.110361","article-title":"Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress","volume":"196","author":"Omoike","year":"2021","journal-title":"Environ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"115424","DOI":"10.1016\/j.envres.2023.115424","article-title":"Short-chain per-and polyfluoralkyl substances (PFAS) effects on oxidative stress biomarkers in human liver, kidney, muscle, and microglia cell lines","volume":"223","author":"Solan","year":"2023","journal-title":"Environ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12291-010-0043-9","article-title":"Role of oxidative stress in various stages of psoriasis","volume":"25","author":"Kadam","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ple\u0144kowska, J., Gabig-Cimi\u0144ska, M., and Mozolewski, P. (2020). Oxidative stress as an important contributor to the pathogenesis of psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176206"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Dobric\u0103, E.-C., Cozma, M.-A., G\u0103man, M.-A., Voiculescu, V.-M., and G\u0103man, A.M. (2022). The involvement of oxidative stress in psoriasis: A systematic review. Antioxidants, 11.","DOI":"10.3390\/antiox11020282"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/EE9.0000000000000238","article-title":"Early-life exposure to per-and polyfluoroalkyl substances and infant gut microbial composition","volume":"7","author":"Laue","year":"2023","journal-title":"Environ. Epidemiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107965","DOI":"10.1016\/j.envint.2023.107965","article-title":"Impact of exposure to per-and polyfluoroalkyl substances on fecal microbiota composition in mother-infant dyads","volume":"176","author":"Lamichhane","year":"2023","journal-title":"Environ. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s13671-017-0178-5","article-title":"The role of the skin and gut microbiome in psoriatic disease","volume":"6","author":"Yan","year":"2017","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sikora, M., Stec, A., Chrabaszcz, M., Knot, A., Waskiel-Burnat, A., Rakowska, A., Olszewska, M., and Rudnicka, L. (2020). Gut microbiome in psoriasis: An updated review. Pathogens, 9.","DOI":"10.3390\/pathogens9060463"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Thye, A.Y.-K., Bah, Y.-R., Law, J.W.-F., Tan, L.T.-H., He, Y.-W., Wong, S.-H., Thurairajasingam, S., Chan, K.-G., Lee, L.-H., and Letchumanan, V. (2022). Gut\u2013skin axis: Unravelling the connection between the gut microbiome and psoriasis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051037"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.berh.2020.101494","article-title":"The gut microbiome in psoriasis and psoriatic arthritis","volume":"33","author":"Myers","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.taap.2011.11.004","article-title":"In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs)","volume":"258","author":"Corsini","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12940-022-00958-5","article-title":"Consideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Ehrlich","year":"2023","journal-title":"Environ. Health"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"139204","DOI":"10.1016\/j.chemosphere.2023.139204","article-title":"Mixtures of per-and poly-fluoroalkyl substances (PFAS) reduce the in vitro activation of human T cells and basophils","volume":"336","author":"Maddalon","year":"2023","journal-title":"Chemosphere"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.crci.2011.04.006","article-title":"New challenges in environmental analytical chemistry: Identification of toxic compounds in complex mixtures","volume":"14","author":"Mazellier","year":"2011","journal-title":"Comptes Rendus Chim."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1289\/ehp.02110s125","article-title":"Understanding the human health effects of chemical mixtures","volume":"110","author":"Carpenter","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Abunada, Z., Alazaiza, M.Y., and Bashir, M.J. (2020). An overview of per-and polyfluoroalkyl substances (PFAS) in the environment: Source, fate, risk and regulations. Water, 12.","DOI":"10.3390\/w12123590"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psep.2022.06.002","article-title":"Distribution, transformation and remediation of poly-and per-fluoroalkyl substances (PFAS) in wastewater sources","volume":"164","author":"Bolan","year":"2022","journal-title":"Process Saf. Environ. Prot."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100421","DOI":"10.1016\/j.ceja.2022.100421","article-title":"Recent advances on PFAS degradation via thermal and nonthermal methods","volume":"13","author":"Verma","year":"2023","journal-title":"Chem. Eng. J. Adv."}],"container-title":["Toxics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6304\/12\/11\/828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:35:14Z","timestamp":1760114114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6304\/12\/11\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["toxics12110828"],"URL":"https:\/\/doi.org\/10.3390\/toxics12110828","relation":{},"ISSN":["2305-6304"],"issn-type":[{"value":"2305-6304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}